Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06189053 · ClinicalTrials.gov registry record
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
A clinical trial of Myocarditis, sponsored by ModernaTX.
- Active
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT06189053: Active study of Myocarditis, sponsored by ModernaTX.
NCT06189053 is a study of Myocarditis that is active but no longer recruiting, run by ModernaTX. The registered enrollment target is 1,500 participants, above the 88-participant average among 5 other Myocarditis trials with a reported enrollment target (1605% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06189053, a study of Myocarditis, is active but no longer recruiting, sponsored by ModernaTX.
- ACTIVE NOT RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this study is to characterize presentation, clinical course, and long-term outcomes of myocarditis temporally associated with administration of mRNA-1273 (SPIKEVAX) COVID-19 vaccine.
Primary Outcome
Adverse clinical outcomes may include myocardial infarction, heart failure, stroke, and cardiovascular hospitalization.
Conditions Studied
Study Locations (1)
Illinois
- Veradigm - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2022-04-30 |
| Est. Completion | 2028-10-31 |
What the registry record for NCT06189053 still lists
NCT06189053 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 88-participant average among 5 other Myocarditis trials with a reported enrollment target (1605% higher).
The record links to 1 condition, with Myocarditis appearing as the primary indexed condition, and to 0 interventions.
NCT06189053 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06189053 about?
NCT06189053 is a clinical study titled "A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)". The main goal of this study is to characterize presentation, clinical course, and long-term outcomes of myocarditis temporally associated with administration of mRNA-1273 (SPIKEVAX) COVID-19 vaccine.
What is the current status of trial NCT06189053?
This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2022-04-30. Estimated completion is 2028-10-31.
What conditions does trial NCT06189053 study?
This clinical trial studies the following conditions: Myocarditis.
Who is sponsoring clinical trial NCT06189053?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06189053 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocarditis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
RECRUITING
-
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
RECRUITING · Phase 4
-
Role of Novel ILR in the Management of PVCs
RECRUITING
-
Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
COMPLETED · Phase 2
-
Evaluation of MyoStrain™ in Clinical Practice
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI